• ABOUT
  • THE GROUP
  • NEWS & MEDIA
  • EVENTS
  • CAREER
  • CONTACT US
  • 0

Gavi®

Genea Gavi® in India

Gavi®
Cryopreservation is a vital component of any Assisted Reproductive Technology (ART) program. In Europe, 37.8% of all embryo transfers involve embryos that have been cryopreserved and subsequently thawed. Vitrification, a flash-freezing process, significantly enhances embryo survival rates post-thaw compared to traditional slow-freezing methods. This technique minimizes the risk of ice formation, ensuring better outcomes for embryo preservation.
Read More
Add to Shortlist

Features & Benefits

  • Innovative Gavi®POD: It is uniquely designed to securely hold oocytes, zygotes, cleavage, and blastocyst stage embryos throughout the vitrification and storage process.
  • High-Quality Results: Our methods deliver blastocyst survival rates that exceed the competency values defined in the ESHRE/ALPHA Vienna consensus on lab performance indicators.
  • Short Learning Curve: This system is user-friendly, requires minimal technical skills, and requires a short time to achieve proficiency.
  • Precise Equilibration Process: This automates and controls critical parameters such as temperature, exposure time, volume, and flow rate during equilibration, ensuring precision and consistency.
  • Controlled, Closed-System Environment: Our controlled, closed-system environment prevents direct contact between embryos and liquid nitrogen (LN2), ensuring safety and integrity.

Product Details

Cryopreservation is a vital component of any Assisted Reproductive Technology (ART) program. In Europe, 37.8% of all embryo transfers involve embryos that have been cryopreserved and subsequently thawed. Vitrification, a flash-freezing process, significantly enhances embryo survival rates post-thaw compared to traditional slow-freezing methods. This technique minimizes the risk of ice formation, ensuring better outcomes for embryo preservation.


However, the current vitrification process is complex and manual, presenting several challenges:


  • Equilibration Variables: Success relies heavily on precise control over the volume and timing of embryos' exposure to cryoprotectant solutions.
  • Manual Handling: Embryologists must manually transfer embryos between solutions, which can introduce stress and potential damage to the embryos.
  • Inconsistent Results: Due to its labour-intensive nature, outcomes can vary between different clinics and practitioners.
  • Highly Skilled Practitioners Required: The process demands extensive training and experience to manage the numerous critical variables effectively.


Genea Biomedex is committed to simplifying and enhancing this process, ensuring consistent, high-quality results in ART programs.
Read More